4//SEC Filing
PROTEOSTASIS THERAPEUTICS, INC. 4
Accession 0000899243-16-032635
CIK 0001445283operating
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:32 PM ET
Size
5.8 KB
Accession
0000899243-16-032635
Insider Transaction Report
Form 4
Gilmartin Greffrey S.
Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-11-01+75,000→ 75,000 totalExercise: $6.98Exp: 2026-08-25→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on August 25, 2017, and thereafter vesting and becoming exercisable in quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on August 25, 2020, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities.
Documents
Issuer
PROTEOSTASIS THERAPEUTICS, INC.
CIK 0001445283
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001445283
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 5:32 PM ET
- Size
- 5.8 KB